Nuclear matrix protein levels in burn patients with multiple organ dysfunction syndrome

Burns

Volumn 25, Issue 8, 1999, Pages 705-708

  Yamada, Y ^a   Endo, S ^a   Nakae, H ^a   Kamei, Y ^a   Taniguchi, S ^a   Ishikura, H ^b   Tanaka, T ^b   Taki, K ^c   Inada, K ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

^b KANSAI MEDICAL UNIVERSITY   (Japan)

^c SAGA UNIVERSITY   (Japan)

Author keywords

Burns; Multiple organ dysfunction; Nuclear matrix proteins

Indexed keywords

MATRIX PROTEIN; NITRATE; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; APOPTOSIS; ARTICLE; BURN; BURN SHOCK; CELL NUCLEUS MATRIX; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; MORBIDITY; MULTIPLE ORGAN FAILURE; SURVIVAL;

ADULT; AGED; ANTIGENS, NUCLEAR; APOPTOSIS; BIOLOGICAL MARKERS; BURNS, INHALATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; NITRIC OXIDE; NUCLEAR PROTEINS; PROGNOSIS; SURVIVAL RATE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032697946     PISSN: 03054179     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0305-4179(99)00069-8     Document Type: Article

References (22)

1. Nakae H., Endo S., Inada K. Plasma levels of endothelin-1 and thrombomodulin in burn patients. Burns. 22:1996;594-597.
2. Yamada Y., Endo S., Kamei Y., et al. Plasma levels of type II phospholipase A2 and nitrite/nitratein patients with burns. Burns. 24:1998;513-517.
3. Goris R.J.A., te Boekhorst T.P.A., Nuytinck K.S., Gimbrere J.S.F. Multiple-organ failure: Generalized autodestructive inflammation? Arch. Surg. 120:1985;1109-1115.
4. Endo S., Inada K., Ceska M., et al. Plasma interleukin 8 and polumorphonuclear leukocyte elastase concentrations in patients with septic shock. J. Inflamm. 45:1995;136-142.
5. Beutler B., Milsark I.W., Cerami A. Cachectin/tumor necrosis factor: production, distribution, and metabolic fate in vivo. J. Immunol. 35:1985;3972-3977.
6. Tracey K.J., Beutler B., Lowry S.F., et al. Shock and tissue injury induced by recombinant human cachectin. Science. 234:1985;470-474.
7. Okusawa S., Gelfand J.A., Ikejima T., et al. Interleukin-1 induces shock-like state in rabbits: Synergism with tumor necrosis factors and effect of cyclooxygenase inhibition. J. Clin. Invest. 81:1988;1162-1172.
8. Endo S., Inada K., Inoue Y., et al. Two types of septic shock classified by the plasma levels of cytokines and endotoxin. Circ. Shock. 38:1992;264-274.
9. Kilbourn R., Jubran A., Gross S.S., et al. Reversa of endotoxin-mediated shock by N-methyl-L-arginine, an inhibitor of nitric oxide synthesis. Biochem. Biophys. Res. Commun. 172:1990;1132-1138.
10. Tanaka M., Suda T., Takahashi T., et al. Expression of the function soluble form of human fas ligand in activated lymphocytes. EMBO J. 14:1995;1129-1135.
11. Lei S.Z., Pan Z., Aggawal S.K., et al. Effects of nitric oxide production on the redox modulatory site of the NMDA receptor-channe complex. Neuron. 14:1992;1087-1099.
12. Endo S., Inada K., Takakuwa T., et al. Nitrite/nitrate (NOx) and sFas antigen levels in patiens with multiple organ failure. Res. Commun. Mol. Pathol. Pharmacol. 92:1996;253-256.
13. Miller T.E., Beausang L.A., Winchell L.F., Lidgard G.P. Detection of nuclear matrix proteins in serum from cancer patients. Cancer. 52:1992;422-427.
14. Miller T.E., Beausang L.A., Meneghini M., Lidgard G. Death-induced cahnges to the nuclera matrix: the use of anti-nuclear matrix antibodies to study agents of apoptosis. Bio Thech. 15:1993;1042-1047.
15. Yamada Y., Endo S., Kasai T., et al. Nuclear matrix protein, tumor necrosis factor-α, and nitrite/nitrate levels in patiens with multiple organ dysfunction syndrome. Res. Commun. Mol. Pathol. Pharmacol. 100:1998;92-104.
16. Members of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992; 101: 1644-1655/Criti. Care Med. 1992; 20: 864-874.
17. Members of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992; 101: 1644-1655/Criti. Care Med. 1992; 20: 864-874.
18. 15N] nitrate in biological fluids. Anal. Biol. 126:1982;131-138.
19. Parchament R. Programmed cell death (apoptosis) in murine blastocytes: extracellular free-radicals, polyamines and other cytotoxic agents. In vitro. 5:1991;493-500.
20. B receptor aggregate in rat hyppocampus CAI subfields following transient forebrain ischemia. J. Neurochem. 63:1994;1042-1051.
21. Sarih M., Souvannavong V., Adam A. Nitric oxide synthase induces macrophage death by apoptosis. Biochem. Biophys. Res. Commun. 191:1993;503-508.
22. Krown K.A., Page M.T., Nguyen C., et al. Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes: involvement of the sphingolipid signaling cascade in cardiac cell death. J. Clin. Invest. 98:1996;2854-2865.